Corium International Inc is a commercial stage biopharmaceutical company. The company develops, manufactures and commercializes specialty pharmaceutical products that leverage its experience in transdermal and transmucosal delivery systems.
Company profile
Website
CEO
Peter D. Staple
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
Latest filings (excl ownership)
15-12B
Securities registration termination
7 Dec 18
EFFECT
Notice of effectiveness
4 Dec 18
EFFECT
Notice of effectiveness
4 Dec 18
EFFECT
Notice of effectiveness
4 Dec 18
S-8 POS
Registration of securities for employees (post-effective amendment)
27 Nov 18
S-8 POS
Registration of securities for employees (post-effective amendment)
27 Nov 18
S-8 POS
Registration of securities for employees (post-effective amendment)
27 Nov 18
S-8 POS
Registration of securities for employees (post-effective amendment)
27 Nov 18
S-8 POS
Registration of securities for employees (post-effective amendment)
27 Nov 18
POS AM
Prospectus update (post-effective amendment)
27 Nov 18
Latest ownership filings
Institutional ownership, Q3 2021
13F holders | Current |
---|---|
Total holders | 0 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 0.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|